Where is Endotex located?

Endotex is headquartered in Cupertino, United States.

How many employees does Endotex have?

As of Jun 30, 2026, the latest employee count at Endotex is 4.

Where does Endotex rank among its competitors?

Endotex ranks 58th amongst 57 active competitors, of which 19 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was XCath, which secured $30M in Mar, 2026.

Who are the top competitors of Endotex?

Endotex's top competitors include Rapid Medical, Penumbra and Cerevast. Among them, XCath secured the most recent funding round in March, 2026.

Endotex - 2026 Company Profile, Team, Funding & Competitors

Endotex is an acqui-hired company based in Cupertino (United States), founded in 1995 by Fred Khosravi. It operates as a Minimally invasive devices for vascular interventions. The company has 57 active competitors, including 19 funded and 15 that have exited. Its top competitors include companies like Rapid Medical, Penumbra and Cerevast.

Company Details

EndoTex Interventional Systems, Inc., a development stage medical device company, engages in the development and manufacture of minimally invasive medical devices for use in the vascular system. It provides solutions for treating carotid artery disease. As of 2007, EndoTex Interventional Systems is a subsidiary of Boston Scientific Corp.

Key Metrics

Founded Year

1995

Location

Cupertino, United States

Stage

Acqui-Hired

Investors

New Enterprise Associates & 1 more

Ranked

58^th among 72 competitors

Employee Count

4 as on Jun 30, 2026

Similar Companies

Rapid Medical & 50 more

View Endotex's full profile

Endotex is a funded company. Endotex has 2 institutional investors.

View details of Endotex's funding rounds and investors

The founders of Endotex is Fred Khosravi.

Here are the details of Endotex's key team members:

Fred Khosravi: Co - Founder of Endotex and founder of 2 other companies, Imperative Care and Hotspur Technologies. They serve on the board of 1 company.
Contact Info: 1 email address

View details of Endotex's Founder profiles and Board Members

Endotex's employee count trend

Endotex has 4 employees as of Jun 26. Here is Endotex's employee count trend over the years:

Uncover Endotex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Endotex include Rapid Medical, Penumbra and Cerevast. Here is the list of Top 10 competitors of Endotex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rapid Medical 2008, Yokneam Illit (Israel), Series D	Developer of neurovascular interventional devices such as distal access & microcatheters	$79M	MicroPort Orthopedics, BRM & 9 others	65/100
2nd	Penumbra 2004, Alameda (United States), Acquired	Developer of medical devices for neurovascular and peripheral thrombectomy	$121K	Novo Holdings, The Angels’ Forum & 4 others	63/100
3rd	Cerevast 2009, Bothell (United States), Series C	Medical device company developing innovative ultrasound and microsphere therapies	$46.9M	Swiftsure, Haiyin Capital	50/100
4th	XCath 2017, Houston (United States), Series C	Developer of endovascular robotics and steerable guidewires	$92M	Crescent Enterprises & 1 others	49/100
5th	Sequent Medical 2007, Aliso Viejo (United States), Acquired	Catheter-based neurovascular devices	$65.3M	Delphi Ventures, Versant Ventures & 4 others	48/100
6th	Terumo Neuro 1997, Aliso Viejo (United States), Unfunded	Developer of minimally-invasive devices for the treatment of vascular diseases in the brain	-	-	46/100
7th	MicroVention 1997, Tustin (United States), Acquired	Innovative neurovascular solutions for hemorrhagic and ischemic stroke treatment	-	Domain Associates, Advanced Technology Ventures ... & 4 others	45/100
8th	Vesselon 2012, Norwalk (United States), Seed	Enhancing drug efficacy and extending patents through innovative co-formulation technology	$1.42M	Design Technologies, Connecticut Innovations ... & 1 others	45/100
9th	BrainsGate 2000, Caesarea (Israel), Series F	Electrical stimulation therapy for CNS diseases	$97M	BNP Paribas, Cipio Partners & 11 others	44/100
10th	Galaxy Therapeutics 2012, Milpitas (United States), Funding Raised	Developer of neurovascular devices to treat brain aneurysms	-	National Science Foundation	44/100
58th	Endotex 1995, Cupertino (United States), Acqui-Hired	Minimally invasive devices for vascular interventions	-	New Enterprise Associates, ONSET Ventures	20/100